ARCH Venture Partners investment considerations forCBRNE products and opportunities

摘要

ARCH is interested in building leading, highly-valued companies from leading research. Toward that endwe value innovations created by the leading researchers in the world, many of which are funded to solvecritical scientific challenges including those in the instrumentation and CBRNE area. The most importantCBRNE innovations we have seen at ARCH are breakthroughs involving significant unaddressedtechnology risk and have the potential for broad proprietary intellectual property as a result. The modelARCH has evolved in instrumentation is to look for a breakthrough innovation, with strong intellectualproperty and continue to strengthen the patent estate through the life of the company. ARCH looks to buildcompanies around leading interdisciplinary scientific and engineering teams, and we favor platformtechnology that can be applied to multiple market applications both commercial and government. As part ofa strategy to build a great company, addressing important CBRNE challenges can help a companystrengthen its technical team and its IP estate. This supports a focus on early low volume markets on theway toward addressing a fuller portfolio of applications. Experienced Venture Capitalists can help thisprocess by identifying important executive talent, partners and applications, offering financial syndicationstrength, and helping shape the company's strategy to maximize the ultimate value realized.